Skip to main content

Advertisement

Log in

Pregnancy-Associated Osteoporosis: A Literature Review

  • Review
  • Published:
Clinical Reviews in Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

Pregnancy-associated osteoporosis (PAO) is a rare pathology affecting women in pregnancy or the postpartum period. During normal pregnancy and lactation, there are substantial physiological changes in the woman’s skeletal structure as well as calcium homeostasis to meet demands of the developing fetus. While these adaptations and generally of no clinical consequence for the mother, and subsequently resolve postpartum, a small number of women will develop osteoporosis and suffer from non-traumatic fragility fractures. Due to the rarity of PAO, systematic study to date has been limited. Etiology is poorly understood, but endocrine effects, nutrient deficiency, genetic predisposition, biomechanical factors, and medication exposures are likely to play a role. Management of PAO is not well understood, due both to a poor evidence base and the rarity of the condition. However, traditional osteoporosis drugs such as bisphosphonates, denosumab, and teriparatide have all been reported in literature. Early diagnosis and treatment of these patients are especially important in the prevention of reoccurrence fractures and to improve the quality of life for these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. The Lancet. 2011;377(9773):1276–87.

    Article  CAS  Google Scholar 

  2. Tella SH, Gallagher JC. Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem Mol Biol. 2014;142:155–70.

    Article  CAS  PubMed  Google Scholar 

  3. Dunne F, Walters B, Marshall T, et al. Pregnancy associated osteoporosis. Clin Endocrinol. 1993;39(4):487–90.

    Article  CAS  Google Scholar 

  4. Nordin B, Roper A. Post-pregnancy osteoporosis. A syndrome P. Lancet. 1955;268:431–434.

  5. Choe EY, Song JE, Park KH, et al. Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures. J Bone Miner Metab. 2012;30(5):596–601.

    Article  CAS  PubMed  Google Scholar 

  6. Hellmeyer L, Hadji P, Ziller V. Osteoporosis in pregnancy Geburtshilfeund Frauenheilkunde. 2004;64:38–45.

    Article  Google Scholar 

  7. O’sullivan S, Grey A, Singh R, et al. Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int. 2006;17(7):1008–12.

    Article  PubMed  Google Scholar 

  8. Hadji P, Boekhoff J, Hahn M, et al. Pregnancy-associated osteoporosis: a case-control study. Osteoporos Int. 2017;28(4):1393–9.

    Article  CAS  PubMed  Google Scholar 

  9. Ghannam N, Hammami M, Bakheet S, et al. Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation. Calcif Tissue Int. 1999;65(1):23–8.

    Article  CAS  PubMed  Google Scholar 

  10. Lebel E, Mishukov Y, Babchenko L, et al. Bone mineral density in gravida: effect of pregnancies and breast-feeding in women of differing ages and parity. J Osteoporos. 2014;2014.

  11. Dahlman TC. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol. 1993;168(4):1265–70.

    Article  CAS  PubMed  Google Scholar 

  12. Ozdemir D, Tam A, Dirikoc A, et al. Postpartum osteoporosis and vertebral fractures in two patients treated with enoxaparin during pregnancy. Osteoporos Int. 2015;26(1):415–8.

    Article  CAS  PubMed  Google Scholar 

  13. Tuna F, Akleylek C, Özdemir H, et al. Risk factors, fractures, and management of pregnancy-associated osteoporosis: a retrospective study of 14 Turkish patients. Gynecol Endocrinol. 2020;36(3):238–42.

    Article  CAS  PubMed  Google Scholar 

  14. Kovacs C, Ralston S. Presentation and management of osteoporosis presenting in association with pregnancy or lactation. Osteoporos Int. 2015;26(9):2223–41.

    Article  CAS  PubMed  Google Scholar 

  15. Sanz-Salvador L, García-Pérez MÁ, Tarin JJ, et al. Bone metabolic changes during pregnancy: a period of vulnerability to osteoporosis and fracture. Eur J Endocrinol. 2014;172(2):R53-65.

    Article  PubMed  Google Scholar 

  16. Polat SB, Evranos B, Aydin C, et al. Effective treatment of severe pregnancy and lactation-related osteoporosis with teriparatide: case report and review of the literature. Gynecol Endocrinol. 2015;31(7):522–5.

    Article  PubMed  Google Scholar 

  17. Silva L, Sampaio L, Pinto J, et al. Osteoporotic fractures in pregnancy-conjunction of factors? Acta Reumatologica Portuguesa. 2009;34(4):641–5.

    PubMed  Google Scholar 

  18. Sharma J, Sharma S, Usha B, et al. Cross-sectional study of serum parathyroid hormone level in high-risk pregnancies as compared to nonpregnant control. Indian J Endocrinol Metab. 2016;20(1):92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Hysaj O, Marqués-Gallego P, Richard A, et al. Parathyroid hormone in pregnancy: vitamin D and other determinants. Nutrients. 2021;13(2):360.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Yadav S, Yadav YS, Goel MM, et al. Calcitonin gene-and parathyroid hormone-related peptides in normotensive and preeclamptic pregnancies: a nested case–control study. Arch Gynecol Obstet. 2014;290(5):897–903.

    Article  CAS  PubMed  Google Scholar 

  21. RiGGs BL, Arnaud CD, Reynolds JC, et al. Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer. J Clin Investig. 1971;50(10):2079–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Sweeney LL, Malabanan AO, Rosen H. Decreased calcitriol requirement during pregnancy and lactation with a window of increased requirement immediately post partum. Endocr Pract. 2010;16(3):459–62.

    Article  PubMed  Google Scholar 

  23. Peris P, Guanabens N, Monegal A, et al. Pregnancy associated osteoporosis: the familial effect. Clin Exp Rheumatol. 2002;20(5):697–700.

    CAS  PubMed  Google Scholar 

  24. Butscheidt S, Delsmann A, Rolvien T, et al. Mutational analysis uncovers monogenic bone disorders in women with pregnancy-associated osteoporosis: three novel mutations in LRP5, COL1A1, and COL1A2. Osteoporos Int. 2018;29(7):1643–51.

    Article  CAS  PubMed  Google Scholar 

  25. Kasahara K, Mimura T, Moritani S, et al. Subchondral insufficiency fracture of the femoral head in a pregnant woman with pre-existing anorexia nervosa. Tohoku J Exp Med. 2018;245(1):1–5.

    Article  PubMed  Google Scholar 

  26. Clemetson I, Popp A, Lippuner K, et al. Postpartum osteoporosis associated with proximal tibial stress fracture. Skeletal Radiol. 2004;33(2):96–8.

    Article  CAS  PubMed  Google Scholar 

  27. Gehlen M, Lazarescu AD, Hinz C, et al. Long-term outcome of patients with pregnancy and lactation-associated osteoporosis (PLO) with a particular focus on quality of life. Clin Rheumatol. 2019;38(12):3575–83.

    Article  PubMed  Google Scholar 

  28. Toba M, Terauchi M, Moriwaki M, et al. Fractures within 2 years of an obstetric hospitalization: analysis of nationwide administrative data in Japan. J Bone Miner Metab. 2022:1–7.

  29. Hardcastle S, Yahya F, Bhalla A. Pregnancy-associated osteoporosis: a UK case series and literature review. Osteoporos Int. 2019;30(5):939–48.

    Article  CAS  PubMed  Google Scholar 

  30. Di Gregorio S, Danilowicz K, Rubin Z, et al. Osteoporosis with vertebral fractures associated with pregnancy and lactation. Nutrition. 2000;16(11–12):1052–5.

    Article  PubMed  Google Scholar 

  31. Baim S, Wilson CR, Lewiecki EM, et al. Precision assessment and radiation safety for dual-energy X-ray absorptiometry: position paper of the International Society for Clinical Densitometry. J Clin Densitom. 2005;8(4):371–8.

    Article  PubMed  Google Scholar 

  32. Ramachandran T. Background radiation, people and the environment. Indian Journal of Environmental Protection. 2011;28(10);914–925

  33. Vokes T, Bachman D, Baim S, et al. Vertebral fracture assessment: the 2005 ISCD Official Positions. J Clin Densitom. 2006;9(1):37–46.

    Article  PubMed  Google Scholar 

  34. Bauer J, Müller D, Ambekar A, et al. Detection of osteoporotic vertebral fractures using multidetector CT. Osteoporos Int. 2006;17(4):608–15.

    Article  CAS  PubMed  Google Scholar 

  35. Kraemer B, Schneider S, Rothmund R, et al. Influence of pregnancy on bone density: a risk factor for osteoporosis? Measurements of the calcaneus by ultrasonometry. Arch Gynecol Obstet. 2012;285(4):907–12.

    Article  PubMed  Google Scholar 

  36. Smith R, Athanasou N, Ostlere S, et al. Pregnancy-associated osteoporosis. QJM: An Int J Med. 1995;88(12):865–878.

  37. Kyvernitakis I, Reuter T, Hellmeyer L, et al. Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up. Osteoporos Int. 2018;29(1):135–42.

    Article  CAS  PubMed  Google Scholar 

  38. Li L-J, Zhang J, Gao P, et al. Clinical characteristics and bisphosphonates treatment of rare pregnancy-and lactation-associated osteoporosis. Clin Rheumatol. 2018;37(11):3141–3150.

  39. Ott SM. Long-term safety of bisphosphonates. Oxford University Press; 2005. p. 1897–1899.

  40. Ringe J, Dorst A, Faber H. Effective and rapid treatment of painful localized transient osteoporosis (bone marrow edema) with intravenous ibandronate. Osteoporos Int. 2005;16(12):2063–8.

    Article  CAS  PubMed  Google Scholar 

  41. Robinson DE, Ali MS, Pallares N, et al. Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis. J Bone Miner Res. 2021;36(5):820–32.

    Article  CAS  PubMed  Google Scholar 

  42. Jain S, Camacho P. Adverse effects of antiresorptive therapy. Osteoporosis: Springer; 2021. p. 135–48.

    Google Scholar 

  43. Rosini S, Rosini S, Bertoldi I, et al. Understanding bisphosphonates and osteonecrosis of the jaw: uses and risks. Eur Rev Med Pharmacol Sci. 2015;19(17):3309–17.

    CAS  PubMed  Google Scholar 

  44. Patlas N, Golomb G, Yaffe P, et al. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology. 1999;60(2):68–73.

    Article  CAS  PubMed  Google Scholar 

  45. Ioannis SP, Chrysoula LG, Aikaterini K, et al. The use of bisphosphonates in women prior to or during pregnancy and lactation. Hormones. 2011;10(4):280–91.

    Article  Google Scholar 

  46. Djokanovic N, Klieger-Grossmann C, Koren G. Does treatment with bisphosphonates endanger the human pregnancy? J Obstet Gynaecol Can. 2008;30(12):1146–8.

    Article  PubMed  Google Scholar 

  47. Hong N, Kim JE, Lee SJ, et al. Changes in bone mineral density and bone turnover markers during treatment with teriparatide in pregnancy-and lactation-associated osteoporosis. Clin Endocrinol. 2018;88(5):652–8.

    Article  CAS  Google Scholar 

  48. Lampropoulou-Adamidou K, Trovas G, Stathopoulos IP, et al. Case report: teriparatide treatment in a case of severe pregnancy-and lactation-associated osteoporosis. Hormones. 2012;11(4):495–500.

    Article  PubMed  Google Scholar 

  49. Winarno A, Kyvernitakis I, Hadji P. Successful treatment of 1–34 parathyroid hormone (PTH) after failure of bisphosphonate therapy in a complex case of pregnancy associated osteoporosis and multiple fractures. Z Geburtshilfe Neonatol. 2014;218(04):171–3.

    Article  CAS  PubMed  Google Scholar 

  50. Lee SH, Hong M-K, Park SW, et al. A case of teriparatide on pregnancy-induced osteoporosis. Journal of Bone Metabolism. 2013;20(2):111–4.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Rajzbaum G, Jakob F, Karras D, et al. Characterization of patients in the European Forsteo Observational Study (EFOS): postmenopausal women entering teriparatide treatment in a community setting. Curr Med Res Opin. 2008;24(2):377–84.

    Article  PubMed  Google Scholar 

  52. Vahle JL, Sato M, Long GG, et al. Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1–34) for 2 years and relevance to human safety. Toxicol Pathol. 2002;30(3):312–21.

    Article  CAS  PubMed  Google Scholar 

  53. Vahle JL, Anderson U, Blomme EA, et al. Use of toxicogenomics in drug safety evaluation: current status and an industry perspective. Regul Toxicol Pharmacol. 2018;96:18–29.

    Article  CAS  PubMed  Google Scholar 

  54. Gilsenan A, Harding A, Kellier-Steele N, et al. The Forteo Patient Registry linkage to multiple state cancer registries: study design and results from the first 8 years. Osteoporos Int. 2018;29(10):2335–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Ozturk C, Atamaz FC, Akkurt H, et al. Pregnancy-associated osteoporosis presenting severe vertebral fractures. J Obstetrics Gynaecol Res. 2014;40(1):288–92.

    Article  CAS  Google Scholar 

  56. Tanriover MD, Oz SG, Sozen T, et al. Pregnancy-and lactation-associated osteoporosis with severe vertebral deformities: can strontium ranelate be a new alternative for the treatment? Spine J. 2009;9(4):e20–4.

    Article  PubMed  Google Scholar 

  57. Nakamura Y, Kamimura M, Ikegami S, et al. A case series of pregnancy-and lactation-associated osteoporosis and a review of the literature. Ther Clin Risk Manag. 2015;11:1361.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Sánchez A, Zanchetta MB, Danilowicz K. Two cases of pregnancy-and lactation-associated osteoporosis successfully treated with denosumab. Clin Cases Miner Bone Metab. 2016;13(3):244.

    PubMed  Google Scholar 

  59. Ijuin A, Yoshikata H, Asano R, et al. Teriparatide and denosumab treatment for pregnancy and lactation-associated osteoporosis with multiple vertebral fractures: a case study. Taiwan J Obstet Gynecol. 2017;56(6):863–6.

    Article  PubMed  Google Scholar 

  60. Bayram S, Ozturk C, Sivrioglu K, et al. Kyphoplasty for pregnancy-associated osteoporotic vertebral fractures. Joint Bone Spine. 2006;73(5):564–6.

    Article  PubMed  Google Scholar 

  61. Terzi R, Terzi H, Özer T, et al. A rare cause of postpartum low back pain: pregnancy-and lactation-associated osteoporosis. BioMed Res Int. 2014;2014.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vitaley Kovalev.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Presentations : None to date.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kovalev, V., Fang, W.H., Pak, T. et al. Pregnancy-Associated Osteoporosis: A Literature Review. Clinic Rev Bone Miner Metab 21, 14–20 (2023). https://doi.org/10.1007/s12018-023-09287-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12018-023-09287-8

Keywords

Navigation